We are excited you are interested in our residency program and furthering care for patients with cancer! Feel free to explore our program via the link below and contact us should you have further questions. We are grateful for the opportunity to provide a glimpse into all the experiences we offer.
The Vanderbilt-Ingram Cancer Center (VICC) is a National Cancer Institute-designated Comprehensive Cancer Center in Nashville, Tennessee that conducts basic, translational and clinical research offering adult and pediatric oncology treatment. Additionally, we are part of the National Comprehensive Cancer Network (NCCN), a non-profit alliance of 27 of the world's leading cancer centers. Our clinicians are privileged to serve more than 6,252 new cancer patients and deliver care for more than 151,000 outpatient visits each year. Comprised of nearly 300 researchers in eight research programs, VICC is also at the forefront of promising new therapies with access to over 150 clinical trials at any given time.
The Department of Pharmacy Specialty Oncology Residency is a 12-month program. The graduate will obtain the specialized oncology knowledge base and clinical skills required to become competent in the pharmaceutical care of cancer patients. We are an accredited residency program by ASHP and follow their guidelines and vision closely. The resident will have opportunities in all aspects of oncology pharmacy practice related to clinical practice and outcomes, short-term research projects, and educating other health care professionals. All rotations are four weeks in duration. The resident schedule is flexible in order to allow the resident to meet his/her career goals and interests.
For additional information please visit our website: PGY2 Oncology |
How to Apply:
Applicant must be a graduate of an accredited Doctor of Pharmacy program, be a licensed pharmacist in any state with reciprocation to Tennessee and completed an accredited PGY1 residency program.
Submit the following application materials to be received by January 2 deadline.
Cover Letter/Letter of Intent
Curriculum Vitae
Three letters of recommendation via PhORCAS
Pharmacy School transcripts
An interview that includes a thirty-minute presentation
Final acceptance depends on required Vanderbilt University Medical Center online application, drug screening and background check. This is not required for initial application through PhORCAS.
For more information or questions regarding the residency or application process, please contact Dr. Rebecca Pokorny at rebecca.pokorny@vumc.org
Vanderbilt University Medical Center offers exceptional PGY2 ASHP-accredited residency programs in both Pharmacy Informatics and Oncology, designed to cultivate future leaders in patient-centered care, technology, and cancer treatment. The Pharmacy Informatics Residency provides immersive training in clinical decision support, medication-use systems, and enterprise-level health IT projects, preparing pharmacists to shape informatics strategy across healthcare settings. The Oncology Residency, based at the nationally recognized Vanderbilt-Ingram Cancer Center, equips residents with advanced clinical skills and research experience in adult and pediatric oncology, supported by access to over 150 clinical trials and a flexible rotation structure. Both programs emphasize teaching, research, and interdisciplinary collaboration, fostering a culture of innovation and excellence.